People with advanced forms of cancer have exhibited favorable clinical response to the long-term use of synthetic cannabidiol (CBD), according to data published in the journal Anticancer Research.

Over 90% of patients in the study exhibited a clinical response to CBD treatment, with some patients experiencing a reduction in tumor cell proliferation and tumor size, NORML reported.
Click here to read more.

Pin It on Pinterest

Share This